Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Environmental Toxicology and Pharmacology
|
July 26, 2011
The effect of the spin trapping agent α-phenyl-n-tert-butyl nitrone on dexfenfluramine-induced serotonin depletion in rat brain
A Bergami, C Fracasso, S Caccia
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 1, 1995
Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates
S Caccia, A Bergami, C Fracasso, et al.
Psychopharmacology
|
March 1, 1995
Effect of d-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymes
M Anelli, C Fracasso, A Bergami, et al.
Neuropharmacology
|
December 1, 1995
Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat
C Fracasso, G Guiso, S Confalonieri, et al.
Pharmacology, Biochemistry, and Behavior
|
August 1, 1997
Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine
S Caccia, S Confalonieri, A Bergami, et al.
Neuroscience Letters
|
November 15, 1996
Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brain
M Gobbi, A Bergami, C Caltavuturo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 24, 2001
Immunological markers in multiple sclerosis
M Gironi, A Bergami, E Brambilla, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 1, 1996
In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat
T Mennini, C Fracasso, A Cagnotto, et al.
Journal of Neuroimmunology
|
November 7, 2000
Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4
R Furlan, A Bergami, R Lang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 8, 1998
A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokines
G Martino, R Furlan, F Galbiati, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Environmental Toxicology and Pharmacology
|
July 26, 2011
The effect of the spin trapping agent α-phenyl-n-tert-butyl nitrone on dexfenfluramine-induced serotonin depletion in rat brain
A Bergami, C Fracasso, S Caccia
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 1, 1995
Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primates
S Caccia, A Bergami, C Fracasso, et al.
Psychopharmacology
|
March 1, 1995
Effect of d-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymes
M Anelli, C Fracasso, A Bergami, et al.
Neuropharmacology
|
December 1, 1995
Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat
C Fracasso, G Guiso, S Confalonieri, et al.
Pharmacology, Biochemistry, and Behavior
|
August 1, 1997
Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine
S Caccia, S Confalonieri, A Bergami, et al.
Neuroscience Letters
|
November 15, 1996
Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brain
M Gobbi, A Bergami, C Caltavuturo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 24, 2001
Immunological markers in multiple sclerosis
M Gironi, A Bergami, E Brambilla, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 1, 1996
In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat
T Mennini, C Fracasso, A Cagnotto, et al.
Journal of Neuroimmunology
|
November 7, 2000
Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4
R Furlan, A Bergami, R Lang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 8, 1998
A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokines
G Martino, R Furlan, F Galbiati, et al.
Page
of 3